399 related articles for article (PubMed ID: 14768061)
1. Identification of a TLR4- and TRIF-dependent activation program of dendritic cells.
Weighardt H; Jusek G; Mages J; Lang R; Hoebe K; Beutler B; Holzmann B
Eur J Immunol; 2004 Feb; 34(2):558-64. PubMed ID: 14768061
[TBL] [Abstract][Full Text] [Related]
2. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway.
Yamamoto M; Sato S; Hemmi H; Hoshino K; Kaisho T; Sanjo H; Takeuchi O; Sugiyama M; Okabe M; Takeda K; Akira S
Science; 2003 Aug; 301(5633):640-3. PubMed ID: 12855817
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional activation induced in macrophages by Toll-like receptor (TLR) ligands: from expression profiling to a model of TLR signaling.
Schmitz F; Mages J; Heit A; Lang R; Wagner H
Eur J Immunol; 2004 Oct; 34(10):2863-73. PubMed ID: 15368303
[TBL] [Abstract][Full Text] [Related]
4. SHP-2 phosphatase negatively regulates the TRIF adaptor protein-dependent type I interferon and proinflammatory cytokine production.
An H; Zhao W; Hou J; Zhang Y; Xie Y; Zheng Y; Xu H; Qian C; Zhou J; Yu Y; Liu S; Feng G; Cao X
Immunity; 2006 Dec; 25(6):919-28. PubMed ID: 17157040
[TBL] [Abstract][Full Text] [Related]
5. TICAM-1 and TICAM-2: toll-like receptor adapters that participate in induction of type 1 interferons.
Seya T; Oshiumi H; Sasai M; Akazawa T; Matsumoto M
Int J Biochem Cell Biol; 2005 Mar; 37(3):524-9. PubMed ID: 15618008
[TBL] [Abstract][Full Text] [Related]
6. Impaired cytokine response in myeloid dendritic cells in chronic hepatitis C virus infection regardless of enhanced expression of Toll-like receptors and retinoic acid inducible gene-I.
Miyazaki M; Kanto T; Inoue M; Itose I; Miyatake H; Sakakibara M; Yakushijin T; Kakita N; Hiramatsu N; Takehara T; Kasahara A; Hayashi N
J Med Virol; 2008 Jun; 80(6):980-8. PubMed ID: 18428149
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of pathogen-specific TLR4 activation in the mucosa: fimbriae, recognition receptors and adaptor protein selection.
Fischer H; Yamamoto M; Akira S; Beutler B; Svanborg C
Eur J Immunol; 2006 Feb; 36(2):267-77. PubMed ID: 16385628
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional regulation of the human TRIF (TIR domain-containing adaptor protein inducing interferon beta) gene.
Hardy MP; McGGettrick AF; O'Neill LA
Biochem J; 2004 May; 380(Pt 1):83-93. PubMed ID: 14960149
[TBL] [Abstract][Full Text] [Related]
9. Regulation of lipopolysaccharide-inducible genes by MyD88 and Toll/IL-1 domain containing adaptor inducing IFN-beta.
Hirotani T; Yamamoto M; Kumagai Y; Uematsu S; Kawase I; Takeuchi O; Akira S
Biochem Biophys Res Commun; 2005 Mar; 328(2):383-92. PubMed ID: 15694359
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of costimulatory molecules induced by lipopolysaccharide and double-stranded RNA occurs by Trif-dependent and Trif-independent pathways.
Hoebe K; Janssen EM; Kim SO; Alexopoulou L; Flavell RA; Han J; Beutler B
Nat Immunol; 2003 Dec; 4(12):1223-9. PubMed ID: 14625548
[TBL] [Abstract][Full Text] [Related]
11. Identification of Lps2 as a key transducer of MyD88-independent TIR signalling.
Hoebe K; Du X; Georgel P; Janssen E; Tabeta K; Kim SO; Goode J; Lin P; Mann N; Mudd S; Crozat K; Sovath S; Han J; Beutler B
Nature; 2003 Aug; 424(6950):743-8. PubMed ID: 12872135
[TBL] [Abstract][Full Text] [Related]
12. Antagonism between MyD88- and TRIF-dependent signals in B7RP-1 up-regulation.
Zhou Z; Hoebe K; Du X; Jiang Z; Shamel L; Beutler B
Eur J Immunol; 2005 Jun; 35(6):1918-27. PubMed ID: 15884053
[TBL] [Abstract][Full Text] [Related]
13. Differential induction of MyD88- and TRIF-dependent pathways in equine monocytes by Toll-like receptor agonists.
Figueiredo MD; Vandenplas ML; Hurley DJ; Moore JN
Vet Immunol Immunopathol; 2009 Jan; 127(1-2):125-34. PubMed ID: 19019456
[TBL] [Abstract][Full Text] [Related]
14. TLR3-mediated IFN-β gene induction is negatively regulated by the TLR adaptor MyD88 adaptor-like.
Siednienko J; Halle A; Nagpal K; Golenbock DT; Miggin SM
Eur J Immunol; 2010 Nov; 40(11):3150-60. PubMed ID: 20957750
[TBL] [Abstract][Full Text] [Related]
15. The human adaptor SARM negatively regulates adaptor protein TRIF-dependent Toll-like receptor signaling.
Carty M; Goodbody R; Schröder M; Stack J; Moynagh PN; Bowie AG
Nat Immunol; 2006 Oct; 7(10):1074-81. PubMed ID: 16964262
[TBL] [Abstract][Full Text] [Related]
16. Suppression of the TRIF-dependent signaling pathway of Toll-like receptors by luteolin.
Lee JK; Kim SY; Kim YS; Lee WH; Hwang DH; Lee JY
Biochem Pharmacol; 2009 Apr; 77(8):1391-400. PubMed ID: 19426678
[TBL] [Abstract][Full Text] [Related]
17. Evolution and integration of innate immune recognition systems: the Toll-like receptors.
Takeda K
J Endotoxin Res; 2005; 11(1):51-5. PubMed ID: 15826379
[TBL] [Abstract][Full Text] [Related]
18. Recipient Toll-like receptors contribute to chronic graft dysfunction by both MyD88- and TRIF-dependent signaling.
Wang S; Schmaderer C; Kiss E; Schmidt C; Bonrouhi M; Porubsky S; Gretz N; Schaefer L; Kirschning CJ; Popovic ZV; Gröne HJ
Dis Model Mech; 2010; 3(1-2):92-103. PubMed ID: 20038715
[TBL] [Abstract][Full Text] [Related]
19. IRF-7 is the master regulator of type-I interferon-dependent immune responses.
Honda K; Yanai H; Negishi H; Asagiri M; Sato M; Mizutani T; Shimada N; Ohba Y; Takaoka A; Yoshida N; Taniguchi T
Nature; 2005 Apr; 434(7034):772-7. PubMed ID: 15800576
[TBL] [Abstract][Full Text] [Related]
20. Poly I:C-induced activation of NK cells by CD8 alpha+ dendritic cells via the IPS-1 and TRIF-dependent pathways.
Miyake T; Kumagai Y; Kato H; Guo Z; Matsushita K; Satoh T; Kawagoe T; Kumar H; Jang MH; Kawai T; Tani T; Takeuchi O; Akira S
J Immunol; 2009 Aug; 183(4):2522-8. PubMed ID: 19635904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
